QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

NASDAQ:XLRNAcceleron Pharma Earnings Date, Estimates & History

$96.04
-3.95 (-3.95 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$95.88
Now: $96.04
$101.71
50-Day Range
$90.94
MA: $98.18
$104.80
52-Week Range
$37.60
Now: $96.04
$110.49
Volume529,530 shs
Average Volume683,228 shs
Market Capitalization$5.17 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.74

Earnings

Acceleron Pharma (NASDAQ:XLRN) Earnings Information

Acceleron Pharma last issued its quarterly earnings data on May 11th, 2020. The biopharmaceutical company reported ($0.95) EPS for the quarter, missing the consensus estimate of ($0.86) by $0.09. The firm earned $4.30 million during the quarter, compared to the consensus estimate of $5.26 million. Its revenue for the quarter was up 53.6% on a year-over-year basis. Acceleron Pharma has generated ($2.38) earnings per share over the last year. Acceleron Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 3rd, 2020 based off prior year's report dates.

Acceleron Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Acceleron Pharma (NASDAQ:XLRN) Earnings Estimates

2020 EPS Consensus Estimate: ($2.99)
2021 EPS Consensus Estimate: ($2.78)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.85)($0.79)($0.83)
Q2 20204($1.04)($0.73)($0.90)
Q3 20204($0.50)($0.03)($0.33)
Q4 20204($1.57)($0.41)($0.93)
Q1 20213($1.12)($0.18)($0.70)
Q2 20213($1.15)$0.17($0.50)
Q3 20213($1.18)($0.04)($0.65)
Q4 20212($1.18)($0.67)($0.93)

Acceleron Pharma (NASDAQ XLRN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/3/2020
(Estimated)
       
5/11/20203/31/2020($0.86)($0.95)($0.95)$5.26 million$4.30 millionTranscript
2/27/2020Q4 2019($0.29)($0.44)($0.44)$35.89 million$39.34 millionTranscript
11/6/2019Q3 2019($0.83)($0.86)($0.86)$4.44 million$4.20 millionTranscript
8/5/2019Q2 2019($0.24)($0.3390)($0.34)$28.72 million$27.67 millionTranscript
5/9/20193/31/2019($0.67)($0.74)($0.74)$3.67 million$2.78 millionListen
2/27/2019Q4 2018($0.67)($0.75)($0.75)$3.21 million$3.80 millionListen
10/30/20189/30/2018($0.66)($0.63)($0.63)$4.37 million$3.30 millionListen
8/2/2018Q2 2018($0.64)($0.63)($0.63)$3.37 million$3.69 millionN/A
5/8/2018Q1 2018($0.64)($0.58)($0.58)$3.77 million$3.23 millionN/A
2/27/2018Q4 2017($0.60)($0.6180)($0.62)$3.39 million$3.71 millionTranscript
11/7/2017Q3 2017($0.67)($0.65)($0.65)$3.52 million$3.00 millionN/A
8/3/2017Q2 2017($0.65)($0.77)($0.77)$3.69 million$3.10 millionListen
5/8/20173/31/2017($0.58)($0.66)($0.66)$3.38 million$3.71 millionListen
3/1/2017Q4 2016($0.57)($0.51)($0.51)$3.74 million$3.37 millionListen
11/3/2016Q3 2016($0.57)($0.55)($0.55)$4.08 million$3.00 millionListen
8/4/2016Q2 2016($0.54)($0.59)($0.59)$3.77 million$3.20 millionListen
5/5/2016Q1 2016($0.29)$0.13$0.13$8.70 million$18.20 millionListen
2/25/2016Q4 2015($0.01)($0.81)($0.81)$15.70 million$3.80 millionListen
11/4/2015Q3 2015($0.41)($0.36)($0.36)$4.38 million$4.16 millionListen
8/6/2015Q2 2015($0.48)($0.32)($0.32)$4.23 million$5.72 millionListen
5/7/2015Q1 2015($0.43)($0.45)($0.45)$3.98 million$4.42 millionN/A
3/2/2015Q4 2014($0.14)($0.55)($0.55)$12.90 million$3.74 millionListen
11/7/2014Q3 2014$0.01($0.25)($0.25)$17.76 million$3.51 millionN/A
8/12/2014Q2 2014($0.55)($0.54)($0.56)$4.08 millionN/A
5/15/2014Q1 2014($0.50)($0.43)($0.56)$2.85 million$3.31 millionTranscript
2/26/2014Q4 2013$0.13($0.14)$0.36$13.66 million$11.50 millionN/A
11/6/2013Q3 2013($0.19)($5.62)($5.62)$8.00 million$4.27 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.